AlgOss Bone Graft Material
Bone augmentation in oral and maxillofacial surgery (e.g., dental implantology)
CommercialActive
Key Facts
Indication
Bone augmentation in oral and maxillofacial surgery (e.g., dental implantology)
Phase
Commercial
Status
Active
Company
About AlgOss Biotechnologies
AlgOss Biotechnologies is an Austrian private company, founded in 2016, focused on pioneering plant-derived biomaterials for bone regeneration. Its core technology platform converts marine algae into bioactive, resorbable bone graft substitutes, offering a natural alternative to synthetic or animal-derived materials. The company appears to be in a commercial or late-stage development phase, with products distributed through specialized partners in the dental and maxillofacial surgery markets. As a pioneer in its niche, AlgOss targets the growing global bone graft substitute market with a potentially superior safety and efficacy profile.
View full company profile